Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Multiple Myeloma 18Hodgkin Disease 10Recurrence 8Lymphoma, Large B-Cell, Diffuse 8Lymphoma 8Leukemia, Myeloid, Acute 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma, Non-Hodgkin 7Breast Neoplasms 7Myelodysplastic Syndromes 6Lymphoma, Mantle-Cell 5Leukemia, Lymphocytic, Chronic, B-Cell 5Carcinoma, Non-Small-Cell Lung 5Waldenstrom Macroglobulinemia 4Neoplasms 4Melanoma 4Lymphoma, Large-Cell, Anaplastic 4Lymphoma, Extranodal NK-T-Cell 4Leukemia 4Immunoblastic Lymphadenopathy 4Glioma 4Sezary Syndrome 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasm Metastasis 3Mycosis Fungoides 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Diffuse Intrinsic Pontine Glioma 3Burkitt Lymphoma 3Solid Tumors 2

Interventions

Cyclophosphamide 64fludarabine phosphate 37Peripheral Blood Stem Cell Transplantation 30Cyclosporine 30Radiotherapy 28Mycophenolic Acid 28Filgrastim 28Busulfan 28Whole-Body Irradiation 26Antilymphocyte Serum 24Melphalan 19Etoposide 19Tacrolimus 16Methotrexate 16Cord Blood Stem Cell Transplantation 16Methylprednisolone 15Rituximab 14Thiotepa 10Cytarabine 10Vincristine 8Prednisone 8Doxorubicin 8Carboplatin 7fludarabine 5Sirolimus 5sargramostim 4glofitamab 4aldesleukin 4Therapeutics 4Leucovorin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Dendritic Cell Sarcoma, Interdigitating × Panobinostat × Clear all
NCT01282476 2017-05-09

Panobinostat With Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma

Massachusetts General Hospital

Phase 2 Terminated
18 enrolled 20 charts
LymphoidSarcoma

Lymphoma, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡